News for Ironwood Pharmaceuticals, Inc. (IRWD)

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Ironwood Pharmaceuticals, Inc.

Net Sales: $916 million for the full year 2024.LINZESS US Net Sales: $223 million in Q4 2024 and $916 million for the full year.Prescription Demand Growth: 11%

Feb 27, 2025 / 01:30PM GMTOperator My name is Kathleen and I will be your conference operator today. At this time I would like to welcome everyone to the Ironwo

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsGreg Martini - Chief Financial...

Ironwood (IRWD) delivered earnings and revenue surprises of -80% and 1.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $90.55 million for Q4 2024, missing the estimated $93.82 million.Earnings Per Share (EPS): $0.02 for Q4 2024, missing the estimated $0.07.Full-Year Re

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living wi

Ironwood Pharmaceuticals Inc (IRWD) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $93.82 million, and th

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction involving Ironwood Pharmaceuticals Inc (IRWD). The firm added 1,

On December 31, 2024, Vanguard Group Inc, a leading investment firm, executed a strategic reduction in its holdings of Ironwood Pharmaceuticals Inc (IRWD). The

**media[521482]**

Ironwood Pharmaceuticals shares surge on competitor's woes

Assertio appoints new independent director to board

**media[485213]**

Beam Therapeutics names Sravan K. Emany as new CFO

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual

LINZESS U.S. Net Sales: $226 million in Q3 2024.Prescription Demand Growth: 13% year-over-year increase in Q3 2024.Operating Cash Flow: $10 million generated i

Nov 07, 2024 / 01:30PM GMTOperator Thank you for standing by. My name is Louella, and I will be your conference operator today. At this time, I would like to we

Loading... Loading... U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday. Shares of Asana, Inc. ASAN rose sharply during Frid...